LNTH Stock Cash Flow Statements

Lantheus Quarterly Cash Flow Statements Chart

Quarterly

Annual

Stock-Based Compensation

Operating Cash Flow

Investing Cash Flow

Financing Cash Flow

Free Cash Flow

Capital Expenditure

Lantheus Quarterly Cash Flow Statements Table

Quarterly

Annual

Unit: USD	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-12-31	2020-09-30	2020-06-30	2020-03-31	2019-12-31	2019-09-30	2019-06-30	2019-03-31	2018-12-31	2018-09-30	2018-06-30	2018-03-31	2017-12-31	2017-09-30	2017-06-30	2017-03-31	2016-12-31	2016-09-30	2016-06-30	2016-03-31	2015-12-31	2015-09-30

cash flows from operating activities:
net income	78,755,000	72,945,000	-11,790,000	131,093,000	62,073,000	131,066,000	103,380,000	131,957,000	94,131,000	-2,807,000	-119,185,000	61,232,000	43,058,000	42,962,000	-40,215,000	-13,415,000	-26,657,000	9,008,000	-3,412,000	-6,386,000	-7,012,000	3,337,000	10,450,000	4,856,000	6,412,000	9,949,000	13,293,000	9,269,000	9,745,000	8,211,000	97,126,000	8,526,000	13,595,000	4,138,000	4,869,000	4,220,000	7,350,000	10,323,000	3,916,000	5,386,000
adjustments to reconcile net income to net cash flows from operating activities:
depreciation, amortization and accretion	13,231,000	13,626,000	17,285,000	17,075,000	14,819,000	15,445,000	15,015,000	14,653,000	15,760,000	14,615,000	11,881,000	12,155,000	12,107,000	11,786,000	12,200,000	12,339,000	9,626,000	8,123,000	8,394,000	8,531,000	4,032,000	3,732,000	3,539,000	3,263,000	3,254,000	3,323,000	3,385,000	3,455,000	3,493,000	3,596,000	4,212,000	3,748,000	5,111,000	6,160,000				4,586,000
adjustment to the fair value of asset retirement obligation	0	-4,727,000
amortization of debt-related costs
inventory adjustments	2,314,000	-1,378,000
stock-based compensation	22,321,000	21,198,000	22,164,000	20,366,000	18,479,000	15,384,000	14,172,000	13,976,000	12,692,000	9,667,000	8,124,000	8,103,000	7,412,000	5,623,000	4,162,000	3,867,000	4,588,000	3,317,000	3,623,000	3,992,000	3,385,000	3,075,000	2,991,000	3,423,000	3,358,000	2,720,000	2,299,000	2,407,000	2,216,000	1,796,000	2,164,000	1,657,000	1,162,000	945,000			585,000	407,000	478,000	591,000
gain on disposal of assets			-2,161,000	0	0	-6,254,000
unrealized gain on investment in equity securities	-14,573,000	14,862,000		-37,325,000	22,537,000	-60,704,000
charges incurred pursuant to acquired in-process research and development	0	5,413,000
deferred taxes	-6,928,000	1,351,000	-25,627,000	3,227,000	-18,889,000	11,260,000	2,017,000	-18,033,000	-3,753,000	-35,863,000	-62,477,000	7,863,000	-7,582,000	14,180,000	3,409,000	-1,657,000	-1,896,000	4,581,000	-553,000	-1,848,000	-400,000	1,467,000	5,935,000	1,403,000	646,000	1,741,000	-1,458,000	2,681,000	1,616,000	2,923,000
long-term income tax payable and other long-term liabilities	-642,000	639,000	2,617,000	1,031,000	1,149,000	439,000	-359,000	-4,130,000	1,263,000	123,000	-11,939,000	-1,692,000	375,000	779,000	-4,295,000	-4,764,000	419,000	728,000	714,000	705,000	704,000	705,000	-14,269,000	-923,000	1,018,000	1,018,000	822,000	880,000	663,000	854,000
other	2,441,000	822,000	5,022,000	2,590,000	2,886,000	1,696,000	1,737,000	1,383,000	510,000	1,225,000	871,000	1,016,000	1,343,000	829,000	788,000	627,000	442,000	655,000	706,000	411,000	-44,000	452,000	193,000	239,000	-4,000	-6,000	398,000	655,000	392,000	-46,000	-355,000	623,000	138,000	643,000	684,000	327,000	-395,000	513,000	-704,000	1,128,000
changes in operating assets and liabilities, excluding impact of acquisitions:
accounts receivable	-2,288,000	-26,363,000	7,202,000	43,141,000	-32,588,000	-55,440,000	-25,593,000	-3,966,000	-14,397,000	-24,681,000	-16,429,000	-11,037,000	-15,839,000	-85,155,000	-25,381,000	-9,272,000	3,897,000	-2,346,000	-6,759,000	-2,790,000	3,837,000	-1,750,000	-2,922,000	4,833,000	-715,000	-1,040,000	3,220,000	-2,982,000	3,593,000	-7,816,000	1,202,000	1,759,000	-3,233,000	-3,135,000	-2,130,000	3,080,000	625,000	-2,634,000	-804,000	-3,468,000
inventory	-5,688,000	278,000	4,431,000	874,000	519,000	-8,494,000	-10,225,000	-6,740,000	-12,131,000	-7,124,000	-2,842,000	-2,653,000	-379,000	-1,634,000	-2,924,000	-2,513,000	-2,001,000	3,889,000	1,134,000	-2,816,000	-4,679,000	-2,098,000	1,266,000	1,093,000	-830,000	465,000	1,142,000	-3,118,000	-135,000	-6,579,000	-3,259,000	-2,129,000	-1,805,000	-2,427,000	-1,968,000	-2,183,000	829,000	-304,000	-168,000	-1,967,000
other current and noncurrent assets
accounts payable	4,383,000	4,982,000	-9,955,000	-5,722,000	10,335,000	-3,462,000	5,039,000	-2,036,000	7,439,000	6,747,000	-8,108,000	9,270,000	-2,367,000	1,506,000	649,000	-1,112,000	1,778,000	4,110,000	-7,986,000	7,214,000	-2,539,000	-913,000	1,779,000	-1,427,000	1,423,000	1,458,000	-5,086,000	5,100,000	-5,060,000	2,160,000	874,000	-1,037,000	-433,000	1,200,000	3,016,000	1,210,000	-596,000	2,070,000	1,085,000	-2,873,000
accrued expenses and other current and noncurrent liabilities	-5,947,000	3,328,000
net cash from operating activities	87,106,000	107,563,000	157,730,000	175,062,000	84,720,000	127,238,000	112,287,000	116,739,000	-32,266,000	108,500,000	105,352,000	93,568,000	72,597,000	10,264,000	13,889,000	4,340,000	25,869,000	9,818,000	569,000	8,575,000	-2,156,000	9,408,000	22,421,000	26,442,000	21,053,000	10,468,000	17,306,000	24,277,000	20,276,000	-666,000	13,086,000	15,600,000	20,567,000	5,524,000
cash flows from investing activities:
capital expenditures	-7,961,000	-8,718,000	-16,369,000	-15,808,000	-11,175,000	-8,273,000	-12,069,000	-14,621,000	-10,697,000	-9,168,000	-4,724,000	-6,090,000	-4,343,000	-3,190,000	-4,544,000	-2,420,000	-2,656,000	-2,520,000	-3,785,000	-3,736,000	-2,255,000	-2,698,000	-4,741,000	-3,336,000	-3,434,000	-10,550,000	-7,366,000	-5,005,000	-5,626,000	-2,135,000	-5,954,000	-3,288,000	-3,402,000	-4,899,000	-2,422,000	-2,588,000	-736,000	-1,652,000	-4,732,000	-2,307,000
free cash flows	79,145,000	98,845,000	141,361,000	159,254,000	73,545,000	118,965,000	100,218,000	102,118,000	-42,963,000	99,332,000	100,628,000	87,478,000	68,254,000	7,074,000	9,345,000	1,920,000	23,213,000	7,298,000	-3,216,000	4,839,000	-4,411,000	6,710,000	17,680,000	23,106,000	17,619,000	-82,000	9,940,000	19,272,000	14,650,000	-2,801,000	7,132,000	12,312,000	17,165,000	625,000
acquisition of in-process research and development
proceeds from sale of assets			9,767,000	0	0	8,000,000	0				0	0	0	1,800,000	0	0	0	15,823,000									0	0	0	1,000,000			899,000	335,000			0	9,000,000
acquisition of assets			0	-47,000,000			0	0	-10,000,000	-35,345,000
acquisition of evergreen, net of cash acquired
purchases of investment in equity securities	0	-5,000,000	0	-4,990,000	0	-78,256,000
acquisition of exclusive license option			0	0	0	-28,000,000
net cash from investing activities	-232,472,000	-63,718,000	-6,602,000	-67,798,000	-45,086,000	-106,529,000	-12,069,000	83,218,000	-20,697,000	-44,513,000	-264,724,000	-6,090,000	-4,343,000	-1,390,000	-4,544,000	-2,420,000			-3,785,000	-3,736,000	5,307,000	-2,698,000	-4,741,000	-3,336,000	-3,434,000	-10,550,000	-7,366,000	-5,005,000	-5,626,000	-1,135,000	-5,954,000	-3,288,000	-2,503,000	-4,564,000
cash flows from financing activities:
payments of long-term debt and other borrowings
proceeds from stock option exercises	2,445,000	3,886,000	-494,000	1,289,000	1,549,000	934,000	354,000	273,000	1,347,000	1,842,000	-1,000	758,000	1,423,000	5,357,000	679,000	530,000	2,043,000	2,043,000	0	27,000			0	729,000	120,000	324,000	0	12,000	626,000	514,000	2,037,000	132,000	446,000	632,000	170,000
proceeds from employee stock purchase plan
payments for minimum statutory tax withholding related to net share settlement of equity awards	-795,000	-23,686,000	-892,000	-1,299,000	-1,006,000	-19,418,000	-773,000	-1,000,000	-1,467,000	-11,154,000	-588,000	-843,000	-824,000	-5,504,000	-187,000	-67,000	-193,000	-1,599,000	-47,000	-50,000	-485,000	-1,547,000	-44,000	-346,000	-944,000	-1,120,000	-218,000	-736,000	-1,723,000	-709,000	-172,000	-1,124,000	-1,202,000	-355,000
repurchase of common stock
net cash from financing activities	-98,413,000	-18,219,000	-103,659,000	1,869,000	99,000	-16,845,000	-450,000	108,000	-4,051,000	-8,669,000	317,840,000	-1,959,000	-2,011,000	-2,179,000	-2,100,000	-1,726,000	-715,000	-34,791,000	-4,373,000	-7,270,000	-6,486,000	-3,732,000	-2,823,000	-1,900,000	-72,927,000	-1,231,000	-934,000	-1,217,000	-1,813,000	-704,000	1,150,000	-1,519,000	-1,827,000	-11,254,000
effect of exchange rate changes on cash, cash equivalents and restricted cash
net increase in cash, cash equivalents and restricted cash	-242,952,000	25,728,000		109,380,000	38,750,000	4,634,000		200,065,000	-56,777,000	55,220,000		85,272,000	66,073,000	6,846,000		-25,000	22,639,000	-11,691,000
cash, cash equivalents and restricted cash, beginning of period	0	914,486,000		0	0	715,285,000		0	0	417,241,000		0	0	100,651,000		0	0	82,694,000		0
cash, cash equivalents and restricted cash, end of period	-242,952,000	940,214,000		109,380,000	38,750,000	719,919,000		200,065,000	-56,777,000	472,461,000		85,272,000	66,073,000	107,497,000		-25,000	22,639,000	71,003,000		-2,315,000
amortization of debt related costs		1,115,000	1,079,000	1,072,000	1,072,000	1,073,000	1,073,000	1,072,000	1,073,000	1,082,000	512,000	246,000	245,000	246,000	246,000	245,000	246,000	-61,000	-80,000	-139,000	169,000	169,000	169,000	170,000	319,000	320,000	320,000	320,000	319,000	320,000	330,000	335,000
changes in assets and liabilities which provided (used) cash:
other current assets		-528,000	3,105,000	-1,831,000	-857,000	4,023,000	-4,914,000	11,756,000	-11,739,000	2,479,000	-2,754,000	-430,000	848,000	-104,000	-2,071,000	-173,000	2,707,000	-536,000	378,000	-179,000	593,000	1,149,000	-2,215,000	-78,000	1,034,000	-1,152,000	-612,000	532,000	422,000	-1,003,000	-442,000	303,000	1,001,000	-1,250,000	877,000	-1,425,000	1,435,000	-1,042,000	943,000	-707,000
deposit for acquisition of a business		-50,000,000
payments on long-term debt and other borrowings		-402,000	58,000	252,000	-444,000	-184,000	-32,000	-157,000	-231,000	-297,000	-167,494,000	-2,672,000	-2,610,000	-2,609,000	-2,591,000	-2,620,000	-2,565,000	-35,572,000	-4,325,000	-4,134,000	-4,481,000	-2,551,000	-2,555,000	-2,574,000	-269,530,000	-717,000
proceeds from issuance of common stock		1,983,000	0	1,627,000	0	1,823,000	0	993,000	0	940,000	0	798,000	0	577,000	-1,000	431,000	0	337,000	0	317,000	0	366,000	0	291,000	0	282,000	0	222,000	0	206,000	0
effect of foreign exchange rates on cash, cash equivalents and restricted cash		102,000		247,000	-983,000	770,000		0	237,000	-98,000		-247,000	-170,000	151,000		-219,000	141,000	-21,000		116,000
operating activities
impairment of long-lived assets							0	0	5,998,000	132,052,000					189,000				2,660,000	0	0	7,275,000
asset retirement obligation acceleration											-949,000	729,000
gain on interest rate swap termination
changes in fair value of contingent assets and liabilities			-1,294,000	-1,505,000			200,000	-500,000	-7,575,000	-1,400,000	9,300,000	-1,500,000	8,500,000	18,400,000	43,900,000	2,600,000	25,600,000	300,000	-2,800,000
charges incurred in connection with acquired ipr&d			0	0	38,000,000	28,000,000
loss on extinguishment of debt																							0	0									0	2,161,000					0	0
benefit from excess and obsolete inventory					-832,000	2,757,000	2,663,000	2,072,000	2,499,000	680,000	2,165,000	1,795,000	666,000	2,519,000	1,740,000	278,000	644,000	1,395,000	495,000	339,000	1,082,000	449,000	152,000	722,000	466,000	511,000	405,000	511,000	739,000	1,220,000	213,000	272,000	445,000	285,000	360,000	164,000	321,000	497,000	286,000	606,000
gain on sale of relistor licensed intangible asset associated with net sales royalties
unrealized loss on investment in equity securities
long-term indemnification receivable							0	4,256,000	-231,000	-96,000
other long-term assets											0	0	0	-533,000
accrued expenses and other liabilities			28,238,000	1,810,000	-33,730,000	50,449,000	8,082,000	22,808,000	-123,805,000	11,801,000	33,201,000	7,011,000	24,400,000	-1,037,000	12,204,000	3,927,000	6,634,000	-6,620,000	2,574,000	1,287,000	-733,000	-7,289,000	3,837,000	8,056,000	2,031,000	-7,847,000	-220,000	5,137,000	2,989,000	-5,656,000	2,288,000	1,543,000	3,890,000	-3,196,000	-1,155,000	4,479,000	2,591,000	-4,573,000	11,000	2,718,000
investing activities
financing activities
debt issuance costs
proceeds from issuance of long-term debt																							0	0							0	0	0	274,313,000					0	0
contingent value rights settlement							0	0
deferred financing costs																			-1,000	2,000			-224,000	0							0	0	-357,000	-1,219,000	0	0			-7,000	-982,000
proceeds from interest rate swap termination
effect of foreign exchange rates on cash and cash equivalents																						-184,000	0	-29,000	132,000	-27,000	-189,000	65,000	-112,000	-46,000	-69,000	130,000	35,000	-2,000	-181,000
net increase in cash and cash equivalents and restricted cash
cash and cash equivalents and restricted cash, beginning of year
cash and cash equivalents and restricted cash, end of year
gain on extinguishment of debt																0	0	-889,000
(decreases) increases in cash from operating assets and liabilities:
(gain) loss on disposal of assets
increases (decreases) in cash from operating assets and liabilities:
lending on bridge loan																			0	0
cash acquired in acquisition of business																			0	0
equity issuance costs																			0	-3,432,000
gain on sale of assets																0	0	-15,263,000																			-117,000	-5,828,000
long-term income tax receivable												1,461,000	-397,000	-396,000		3,823,000	-158,000	-573,000	-554,000	-555,000	-555,000	-554,000	11,477,000	762,000	-802,000	-802,000	-635,000	-692,000	-687,000	-841,000
aro acceleration														293,000
(gain) loss on extinguishment of debt
net cash from provided by investing activities																		13,303,000
loss on disposal of assets
benefit from bad debt																				9,000	4,000	202,000	39,000	50,000	247,000	-190,000	33,000	122,000	-29,000	195,000
net decrease in cash, cash equivalents and restricted cash																				-2,315,000
net increase in cash and cash equivalents																						2,794,000	14,857,000	21,177,000			8,817,000	18,120,000			8,213,000	10,923,000	16,272,000	-10,296,000
cash and cash equivalents, beginning of period																						92,919,000		0	0	113,401,000		0	0	76,290,000		0	0	51,178,000		0	0	28,596,000		0
cash and cash equivalents, end of period																						95,713,000		21,177,000	-55,176,000	112,061,000		18,120,000	12,725,000	73,739,000		10,923,000	16,272,000	40,882,000		-1,656,000	15,971,000	38,880,000		-278,000
loss on impairment of land
payments for public offering costs
cash and cash equivalents, beginning of year
cash and cash equivalents, end of year
net decrease in cash and cash equivalents																										-1,340,000				-2,551,000
gain on sales of assets																																			120,000
loss on extinguishment of debt and debt retirement costs																															281,000
payments on long-term debt																											-716,000	-715,000	-716,000	-715,000	-715,000	-714,000	-714,000	-284,551,000			-928,000	-933,000	-931,000
write-off of deferred offering and financing costs
income taxes																																						-235,000
payments on senior notes																																							0
payment for call premium on senior notes																																							0	0
net movement in line of credit
proceeds from sales of assets
redemption of certificate of deposit—restricted
debt retirement costs																																			481,000
supplemental disclosure of cash flow information
cash paid during the period for:
interest
income taxes, net of refunds of 82, 363 and 317, respectively
schedule of non-cash investing and financing activities
additions of property, plant & equipment included in liabilities
receivable in connection with sale of australian subsidiary
adjustments to reconcile net income to cash flows from operating activities:
depreciation and amortization																																				3,842,000				4,075,000
stock-based compensation expense
changes in operating assets and liabilities:
cash from operating activities																																				15,446,000	17,635,000	3,780,000	12,626,000	5,417,000
redemption of certificate of deposit – restricted
cash from investing activities																																				-1,047,000	-736,000	7,422,000	-4,732,000	-2,307,000
proceeds from issuance of common stock in public offering
payments for offering costs																																							0	0
principal payments on long-term debt
principal payments on senior notes
repayments of amounts borrowed under revolving line of credit
payments of minimum statutory tax withholdings on net share settlements of equity awards
cash from financing activities																																				-16,086,000	-928,000	-944,000	-1,042,000	-3,014,000
increase in cash and cash equivalents																																				-1,656,000	15,971,000	10,284,000	6,674,000	-278,000
cash flows from operating activities
adjustments to reconcile net income to cash flow from operating activities
increase in cash from operating assets and liabilities
cash flows from investing activities
redemption of certificate of deposit - restricted																																					0	74,000
cash flows from financing activities
proceeds from issuance of common stock in initial public offering																																							0	0
payments for initial public offering costs
payments on line of credit																																							0	0
payments on note payable
effect of foreign exchange rate on cash																																					0	26,000	-178,000	-374,000
interest paid																																					6,368,000	6,422,000	6,513,000	6,534,000
income taxes paid																																							93,000	8,000
income taxes paid/(refunded)																																						199,000
cash flow from operating activities
impairment of land
impairment of intangible assets
proceeds from sale of property, plant and equipment
proceeds from line of credit
proceeds from issuance of common stock, other
payments for common stock repurchase
payments for tax withholding related to net share settlement of equity awards
payments of dividend
noncash investing and financing activities
property, plant and equipment included in accounts payable and accrued expenses and other liabilities																																							185,000	-636,000
deferred offering cost included in accounts payable and accrued expenses and other liabilities
deferred income taxes																																								-72,000
write-off of deferred financing costs
initial public offering costs																																								-1,003,000
payment for tax withholding related to net share settlement of equity awards
initial public offering costs included in accrued expenses and other liabilities
payments of senior notes
initial public offering costs included in accounts payable and accrued expenses and other liabilities
deferred financing costs included in accrued expenses and other liabilities

We provide you with 20 years of cash flow statements for Lantheus stock, allowing you to gain comprehensive visibility into the fundamentals of the company. Our detailed breakdowns include key financial metrics such as operating cash flows, cash levels, capital expenditures, profits, stock-based compensations and profit margins. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of Lantheus stock. Explore the full financial landscape of Lantheus stock with our expertly curated income statements.

The information provided in this report about Lantheus stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.